Explained: Efficacy in 50 pc cases and other CDSCO draft guidelines for Covid-19 vaccines approval - The Indian Express

1. Explained: Efficacy in 50 pc cases and other CDSCO draft guidelines for Covid-19 vaccines approval  The Indian Express
2. Phase 3 clinical trial for vaccine being developed by China begins in Pakistan  DAWN.com
3. Phase III trials for Chinese company Cansinobio's COVID-19 vaccine launched: NCOC  The Express Tribune
4. Coronavirus Vaccine Trials Could Suffer From Shortcuts  The New York Times
5. Op-Ed: Vaccine doubter may pose issues for COVID-19 vaccine  Los Angeles Times
6. View Full coverage on Google News

from Top stories - Google News https://ift.tt/2G1ZIHu